Mach aus dieser Rolle ein Bewerbungsgespräch — ein Lebenslauf und ein Anschreiben, die genau auf das zugeschnitten sind, was dieser Arbeitgeber sucht.
Medical University of Graz invites applications for a PhD research position to study cell-based characterization of IDRs binding to β-catenin. The project, funded by Horizon Europe MSCA, aims to understand transcriptional condensates and how inhibitors affect β-catenin recruitment in cells.
The candidate should have a strong background in cell biology, molecular biology, biochemistry, or related fields, with experience in mammalian cell culture, molecular cloning, fluorescence microscopy, and
Organisation/Company Medical University of Graz Research Field Chemistry Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 31 Oct 2026 - 23:59 (Europe/Vienna) Country Austria Type of Contract Temporary Job Status Full-time Hours Per Week 40 Offer Starting Date 1 Jan 2027 Is the job funded through the EU Research Framework Programme? Horizon Europe - MSCA Marie Curie Grant Agreement Number 101311592 Is the Job related to staff position within a Research Infrastructure? Yes
Medical University of Graz
Project Title: Cell-based characterization of IDRs binding to β-catenin
Objectives:
1. Characterize interaction of novel IDRs with β-catenin in cells.
2. Reveal the functional consequences of β-catenin-mediated regulation of novel IDR-containing proteins.
3. Identify how novel β-catenin inhibitors regulate formation of transcriptional condensates and gene transcription.
Project Overview: We aim to improve our understanding of interactions and functional consequences of the IDR/β-catenin network. Recently, several labs, including the Madl lab, have shown that β-catenin, like several other TFs, partitions into biomolecular condensates with the transcriptional machinery and that this is necessary for efficient transcriptional activation. Perturbing condensates is currently actively explored as a potential therapeutic strategy, and a better understanding of the mechanisms that regulate condensation informs these efforts. This project builds on expertise in transcription factor condensate and cell biology in the Madl group at MUG, also involving expertise in cellular models (Boehringer Ingelheim) and mass spectrometry (Bonaldi, UMI) to characterize the interaction network of IDRs with β-catenin and RNA in cells, functional consequences and modulation of β-catenin/IDR interactions by inhibitors. The innovation is the focus on transcriptional condensates as a novel and promising target for inhibitors, which is strongly facilitated in this doctoral network. These combined efforts will answer conceptual questions about β-catenin role in regulating TFs via formation of transcriptional condensates and the functional consequences of inhibiting TF recruitment to these condensates. Contribution to the overall research program: Understanding of the mechanism of β-catenin regulation of transcriptional condensates to reveal potential new targeting mechanisms and cellular pathways.
Skills and research profile: We seek a highly motivated candidate with a strong background in cell biology, molecular biology, biochemistry, cancer biology, or a related field and a keen interest in transcriptional regulation, intrinsically disordered proteins, and biomolecular condensates. Experience in mammalian cell culture, molecular cloning, fluorescence microscopy, protein–protein interaction studies, and/or gene-expression analysis is highly desirable. Experience with advanced imaging, transcriptional assays, proteomics, or quantitative analysis of biomolecular condensates is advantageous but not essential. Experience with advanced imaging, transcriptional assays, proteomics, or quantitative analysis of biomolecular condensates is advantageous but not essential. The candidate should be interested in combining cell-based characterization of β-catenin/IDR interactions with functional studies of transcriptional condensates, gene regulation, and pharmacological perturbation using novel β-catenin inhibitors. Strong analytical skills, enthusiasm for interdisciplinary and collaborative research, and willingness to undertake
international secondments within the FlexCAT network are expected.
Salary: The position is funded by the Horizon Europe MSCA-DN project FlexCAT (Grant Agreement No. 101311592) for three years. The selected candidate will be offered a competitive salary comprising a Living Allowance (adjusted by the country correction coefficient), a Mobility Allowance, and, if applicable, a Family Allowance. All allowances are subject to applicable social security contributions and taxation. Subject to availability, additional funding may be provided by the host institution and/or the supervising PI to support employment for a fourth year, where required or beneficial for completion of the doctoral
programme.
Planned secondment: to be determined
Purpose: Interaction studies of selected novel IDRs with β-catenin in cells.
Enrolment in Doctoral degree(s): International PhD Program BioMolStruct at MUG (Madl)
Applicants of any nationality are welcome to apply. To be eligible for recruitment as an MSCA Doctoral Candidate, applicants must fulfil the following criteria at the date of recruitment:
Languages ENGLISH Level Excellent
Research Field Chemistry Years of Research Experience 1 - 4
Selection process
Applications will be assessed for eligibility and scientific/academic quality. Shortlisted applicants will be invited to interview. The final selection will follow the open, transparent and merit-based recruitment principles of MSCA.